636
Views
72
CrossRef citations to date
0
Altmetric
Original Article

Gold-nanobeacons for gene therapy: evaluation of genotoxicity, cell toxicity and proteome profiling analysis

, , , , , , , & show all
Pages 521-532 | Received 19 Feb 2013, Accepted 02 May 2013, Published online: 28 May 2013
 

Abstract

Antisense therapy is a powerful tool for post-transcriptional gene silencing suitable for down-regulating target genes associated to disease. Gold nanoparticles have been described as effective intracellular delivery vehicles for antisense oligonucleotides providing increased protection against nucleases and targeting capability via simple surface modification. We constructed an antisense gold-nanobeacon consisting of a stem-looped oligonucleotide double-labelled with 3′-Cy3 and 5′-Thiol-C6 and tested for the effective blocking of gene expression in colorectal cancer cells. Due to the beacon conformation, gene silencing was directly detected as fluorescence increases with hybridisation to target, which can be used to assess the level of silencing. Moreover, this system was extensively evaluated for the genotoxic, cytotoxic and proteomic effects of gold-nanobeacon exposure to cancer cells. The exposure was evaluated by two-dimensional protein electrophoresis followed by mass spectrometry to perform a proteomic profile and 3-(4,5-Dimethylthiazol-2-Yl)-2,5-Diphenyltetrazolium Bromide (MTT) assay, glutathione-S-transferase assay, micronucleus test and comet assay to assess the genotoxicity. This integrated toxicology evaluation showed that the proposed nanotheranostics strategy does not exhibit significant toxicity, which is extremely relevant when translating into in vivo systems.

Acknowledgements

This work was funded by Fundação para a Ciência e Tecnologia, Ministry of Science and Education (FCT/MEC): CIGMH (PEst-OE/SAU/UI0009/2011); REQUIMTE (PEst-C/EQB/LA0006/2011); PTDC/QUI-QUI/112597/2009; PTDC/CTM-NAN/109877/2009; PTDC/BBB-NAN/1812/2012; J.C. for SFRH/BD/62957/2009; ML for SFRH/BD/64026/2009; PC for SFRH/BPD/72564/2010; LRR for SFRH/BD/70202/2010. Additional funding was from the Nanotruck-Action from NanoSciEra+.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.